Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer

The identification of better regimens in currently available chemotherapeutic agents is crucial for treating patients with KRAS mutant metastatic colorectal cancer (mCRC). Records of mCRC patients who received first-line oxaliplatin-based or irinotecan-based regimens were reviewed retrospectively. C...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lin, Yu-Lin, Liau, Jau-Yu, Yu, Shan-Chi, Tseng, Li-Hui, Lin, Liang-In, Liang, Jin-Tung, Lin, Ben-Ren, Hung, Ji-Shiang, Chang, Yih-Leong, Yeh, Kun-Huei, Cheng, Ann-Lii
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Neoplasia Press Inc. 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3660806/
https://ncbi.nlm.nih.gov/pubmed/23730417
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller